3.90
-0.1(-2.50%)
Currency In USD
| Previous Close | 4 |
| Open | 4.03 |
| Day High | 4.09 |
| Day Low | 3.9 |
| 52-Week High | 41.22 |
| 52-Week Low | 3.56 |
| Volume | 8,417 |
| Average Volume | 90,877 |
| Market Cap | 9.83M |
| PE | -0.31 |
| EPS | -12.53 |
| Moving Average 50 Days | 4.52 |
| Moving Average 200 Days | 9.08 |
| Change | -0.1 |
If you invested $1000 in Imunon, Inc. (IMNN) 10 years ago, it would be worth $0.67 as of December 06, 2025 at a share price of $3.9. Whereas If you bought $1000 worth of Imunon, Inc. (IMNN) shares 5 years ago, it would be worth $27.96 as of December 06, 2025 at a share price of $3.9.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
IMUNON Public Webcast Highlights Resilience and Innovation in Pursuit of the First Approved Immunotherapy for Ovarian Cancer
GlobeNewswire Inc.
Nov 10, 2025 6:30 PM GMT
Webcast Recording and Symposium Slides Now Available LAWRENCEVILLE, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today hosted a compelling
IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer
GlobeNewswire Inc.
Nov 10, 2025 12:30 PM GMT
Event being held today at 8:00 a.m. ET in New York City features presentations from Ovarian Cancer Key Opinion Leaders, Clinicians, Statistical Experts, and IMUNON executives Investors, stakeholders, analysts and those interested in advances in ovari
IMUNON R&D Day: Opportunity to Hear Clinical Trial Investigators Discuss Significant Potential of IMNN-001 to Redefine Ovarian Cancer Treatment
GlobeNewswire Inc.
Nov 07, 2025 1:05 PM GMT
Investors and stakeholders invited to attend in person in New York City or via live webcast on Monday, November 10th at 8:00 a.m. ET LAWRENCEVILLE, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Pha